Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis
The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
Hereditary hemochromatosis is a prevalent genetic disorder of iron hyperabsorption leading to hyperferremia, tissue iron deposition and complications including cirrhosis, hepatocarcinoma, cardiomyopathy and diabetes. Most individuals affected with hereditary hemochromatosis are homozygous with respect to a missense mutation that disrupts the conformation of HFE, an atypical HLA class I molecule (ref. 1; OMIM 235200). Mice lacking Hfe or producing a C282Y mutant Hfe protein develop hyperferremia and have high hepatic iron levels. In both humans and mice, hereditary hemochromatosis is associated with a paucity of iron in reticuloendothelial cells. It has been suggested that HFE modulates uptake of transferrin-bound iron by undifferentiated intestinal crypt cells, thereby programming the absorptive capacity of enterocytes derived from these cells; however, this model is unproven and controversial. Hepcidin, a peptide hormone (HAMP; OMIM 606464), seems to act in the same regulatory pathway as HFE. Although expression of mouse Hamp is normally greater during iron overload, Hfe-/- mice have inappropriately low expression of Hamp. We crossed Hfe-/- mice with transgenic mice overexpressing Hamp and found that Hamp inhibited the iron accumulation normally observed in the Hfe-/- mice. This argues against the crypt programming model and suggests that failure of Hamp induction contributes to the pathogenesis of hemochromatosis, providing a rationale for the use of HAMP in the treatment of this disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, transgenic expression of hepcidin prevented iron overload in Hfe−∕− (Nicolas et al., 2003) and Hbbth3∕+ (Gardenghi et al., 2010) mice, models of HH and β-thalassemia intermedia, respectively.”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Nicolas et al., 2003
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664 · cited 1×
“Most individuals affected with hereditary hemochromatosis are homozygous with respect to a missense mutation that disrupts the conformation of HFE, an atypical HLA class I molecule (ref”
BackgroundHepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697 · cited 1×
“It is synthesized predominantly in the liver, secreted as peptides of 20–25 amino acid”
BackgroundHepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417 · cited 1×
“Other individuals with anemia and inflammation have been reported with elevated urinary HAMP excretio”
BackgroundLEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Self-citationNicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214 · cited 1×
“Hamp -deficient mice are unresponsive to the hypoferremic effects of inflammation provoked by turpentine injectio”
BackgroundSelf-citationSevere iron deficiency anemia in transgenic mice expressing liver hepcidin
Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., Sirito, M., Sawadogo, M., Kahn, A., & Vaulont, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072632499 · Cited by 880
Self-citationMutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C. (2003) · Nature Genetics · doi:10.1038/ng1053 · Cited by 860 · cited 1×
“Recently, humans with severe hemochromatosis have been shown to have null mutations in the gene HAMP”
BackgroundWeinstein, D. A., Roy, C. N., Fleming, M. D., Loda, M. F., Wolfsdorf, J. I., & Andrews, N. C. (2002) · Blood · doi:10.1182/blood-2002-04-1260 · Cited by 632 · cited 1×
“Humans with constitutively active HAMP expression develop iron-refractory anemia associated with defective intestinal iron absorption and macrophage iron retention, similar to the anemia of chronic inflammatio”
BackgroundSelf-citation
Cited by
Items 201–300 of 310
Ka, C., Gac, G. L., Dupradeau, F., Rochette, J., & Férec, C. (2005) · Human Genetics · doi:10.1007/s00439-005-1307-y · Cited by 20
“On the other hand, recent publications have confirmed that HFE is significantly expressed in hepatocytes (Zhang et al. 2004) and plays an important role in the regulation of hepcidin synthesis (Bridle et al. 2003; Nicolas et al. 2003; Muckenthaler et al. 2003).”
BackgroundChung, R. T., Misdraji, J., & Sahani, D. V. (2006) · New England Journal of Medicine · doi:10.1056/nejmcpc069024 · Cited by 17
Ferrara, F., Corradini, E., & Pietrangelo, A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_54 · Cited by 17
A tincture of hepcidin cures all: the potential for hepcidin therapeutics
Bartnikas, T. B., & Fleming, M. D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci45043 · Cited by 16
Role of Hepcidin in Iron Metabolism and Potential Clinical Applications
Grimes, C. N., Giori, L., & Fry, M. M. (2012) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2011.10.002 · Cited by 21
Intestinal absorption of iron in HFE-1 hemochromatosis: local or systemic process?
Brissot, P., Troadec, M., & Loréal, O. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.01.020 · Cited by 19
Ismail, M. K., Waters, B., Martínez‐Hernández, A., Schichman, S. A., & Chaudhry, S. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181719b4b · Cited by 16
Impaired regulation of serum hepcidin during phlebotomy in patients with chronic hepatitis C
Sugimoto, R., Fujita, N., Tomosugi, N., Hara, N., Miyachi, H., Tanaka, H., Takeo, M., Nakagawa, N., Iwasa, M., Kobayashi, Y., et al. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00497.x · Cited by 15
Ischemia‐reperfusion of rat liver modulates hepcidin in vivo expression
Goss, J. A., Seu, P., Gao, F. Q., & Wyllie, S. (2005) · Liver Transplantation · doi:10.1002/lt.20436 · Cited by 16
Brandão, M., Oliveira, J. C., Bravo, F., Reis, J., Garrido, I., & Porto, G. (2005) · PubMed · Cited by 17
Hepcidin and its multiple partners: Complex regulation of iron metabolism in health and disease
Ginzburg, Y. Z. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2023.03.001 · Cited by 20
Three signalling pathways for iron overload in osteoporosis: a narrative review
Zou, L., Chen, G., Rong, Y., Tang, C., Lv, X., & Fan, Y. (2025) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-025-05588-4 · Cited by 15
“Interestingly, Nicolas et al. [27] found that overexpression of the hepcidin gene (HAMP) could significantly reduce iron deposition in parenchymal cells of mice with hereditary hemochromatosis.”
Striking the target in iron overload disorders
Finberg, K. E. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68889 · Cited by 18
“Transgenic overexpression of hepcidin has been shown to limit iron loading in a mouse model of TI (3) and to prevent hepatic iron overload in a mouse model of HFE -associated hemochromatosis ( HFE - HH), the most common inherited form of hemochromatosis resulting from mutation in the HFE gene (4).”
Distinct Iron Deposition Profiles of Liver Zones in Various Models with Iron Homeostasis Disorders
Song, H., Zhang, S., Sun, X., Liu, J. L., Wu, Y., Guo, W., Wang, F., Ou, X., Cong, M., Jin, E., et al. (2018) · Advanced Science · doi:10.1002/advs.201800866 · Cited by 13
Viprakasit, V., Vathesathokit, P., Chinchang, W., Tachavanich, K., Pung‐Amritt, P., Wimhurst, V. L. C., Yenchitsomanus, P., Merryweather‐Clarke, A. T., & Tanphaichitr, V. S. (2004) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00246.x · Cited by 16
Prospects for a hepcidin mimic to treat β-thalassemia and hemochromatosis
Parrow, N. L., Gardenghi, S., & Rivella, S. (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.22 · Cited by 17
Hémochromatose HFE : approche pathogénique et diagnostique
Brissot, P., Lan, C. L., Troadec, M., Lorho, R., Ropert, M., Lescoat, G., & Loréal, O. (2005) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2005.04.040 · Cited by 14
Role of HAMP Genetic Variants on Pathophysiology of Iron Deficiency Anemia
Pandey, S., Pandey, S. K., & Shah, V. (2017) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-017-0707-9 · Cited by 13
Non-HFE hemochromatosis: Genetics, pathogenesis, and clinical management
Nelson, J. E., & Kowdley, K. V. (2005) · Current Gastroenterology Reports · doi:10.1007/s11894-005-0069-y · Cited by 12
“Hepcidin overexpression results in mice with fatal iron deficiency anemia [21], and that constitutive expression of Hamp prevented iron overload in Hfe-/- mice [ 22 ].”
BackgroundDietary supplementation with ipriflavone decreases hepatic iron stores in wild type mice
Patchen, B., Koppe, T., Cheng, A., Seo, Y. A., Wessling‐Resnick, M., & Fraenkel, P. G. (2016) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2016.05.004 · Cited by 12
“Because its levels are inappropriately low in patients with iron overload syndromes[6] and experimental over-expression of hepcidin or injection of synthetic hepcidin improves iron overload in mouse models[7, 8], Hepcidin is a potential drug target for the treatment of tissue iron accumulation.”
BackgroundWest, A. R., Thomas, C., Sadlier, J., & Oates, P. S. (2005) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0060-6 · Cited by 16
“Typically, hepcidin levels vary inversely with the efficiency of iron absorption (Laftah et al. 2004; Nicolas et al. 2001; Nicolas et al. 2003).”
BackgroundHöblinger, A., Erdmann, C., Straßburg, C., Sauerbruch, T., & Lammert, F. (2009) · European journal of medical research · doi:10.1186/2047-783x-14-4-182 · Cited by 12
“Moreover, overexpression of hepcidin in HFE deficient mice prevents or delays hepatic iron accumulation [27, 28].”
BackgroundHereditary hemochromatosis: An opportunity for gene therapy
Ezquer, F. E., Núñez, M. T., Rojas‐Fernández, A., Asenjo, J. A., & Israel, Y. (2006) · Biological Research · doi:10.4067/s0716-97602006000100014 · Cited by 15
“In another study, Nicolas et al. (2003) crossed mice that overexpressed hepcidin with mice that were hfe -/-deficient; the mouse model of hereditary hemochromatosis.”
Bhatt, L., Murphy, C., O’Driscoll, L. S., Carmo‐Fonseca, M., McCaffrey, M., & Fleming, J. V. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07727.x · Cited by 11
Regulatory variation in hepcidin expression as a heritable quantitative trait
Bayele, H. K., & Srai, S. K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.032 · Cited by 11
Scotet, V., Saliou, P., Uguen, M., L’Hostis, C., Mérour, M.-C., Triponey, C., Chanu, B., Nousbaum, J. B., Gac, G. L., & Férec, C. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1684-6 · Cited by 7
“The hepatic expression of hepcidin [40] and its regulator (BMP6) [41] was reduced in multiparous females, suggesting that the inhibition of intestinal iron absorption was inactivated in response to pregnancy.”
BackgroundIron Metabolism and Related Disorders
Hoda, K., Bowlus, C. L., Chu, T. W., & Gruen, J. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00106-3 · Cited by 8
Baek, J. H., Shin, H. K., Gao, Y. S., & Buehler, P. W. (2020) · Transfusion · doi:10.1111/trf.15720 · Cited by 8
“, β-thalassemia intermedia and hereditary hemochromatosis) exhibit increased iron intestinal absorption, macrophage transport, circulatory accumulation, tissue deposition, and injury in murine models.(21,22) Oral and subcutaneously administered hepcidin analogs, and synthetic small-molecule inhibitors of FPN, are bein…”
BackgroundLiver transplantation: An “ in vivo ” model for the pathophysiology of hemochromatosis?†
Kowdley, K. V. (2004) · Hepatology · doi:10.1002/hep.20269 · Cited by 8
Hepcidina, una nueva proteína en la homeostasis del hierro
Rueda, A. D. C., & Álvarez, J. D. P. (2003) · Anales de Medicina Interna · doi:10.4321/s0212-71992003001200001 · Cited by 12
Saliou, P., Gac, G. L., Mérour, M.-C., Tripogney, C., Chanu, B., Gourlaouen, I., Nousbaum, J., Férec, C., & Scotet, V. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2343-x · Cited by 6
“It is obvious that the regulation of intestinal iron absorption by hepcidin is failing in C282Y homozygotes [10].”
BackgroundErythroferrone: the missing link in β-thalassemia?
Moura, I. C., & Hermine, O. (2015) · Blood · doi:10.1182/blood-2015-09-665596 · Cited by 7
“Hepcidin, a small peptide mainly produced by the liver, is absolutely required for the maintenance of systemic iron homeostasis in basal conditions.(6) Hepcidin controls serum iron levels by binding to ferroportin (FPN), the only known iron exporter, and inducing its degradation.”
BackgroundAlcohol intake and iron overload: Another role for hepcidin?
Kowdley, K. V. (2007) · Hepatology · doi:10.1002/hep.21544 · Cited by 8
Hepcidina: hormona reguladora del metabolismo del hierro en el deportista
Domínguez, R., & Muñoz-Maté, J. (2014) · Revista Iberoamericana de Ciencias de la Actividad Física y el Deporte · doi:10.24310/riccafd.2014.v3i1.6179 · Cited by 7
[Iron metabolism, overview and recent insights].
Omar, S., Feki, M., & Kaabachi, N. (2006) · PubMed · Cited by 20
Ferroptosis in Hemolytic Disorders
Youssef, L. A., & Spitalnik, S. L. (2019) · Springer eBooks · doi:10.1007/978-3-030-26780-3_15 · Cited by 4
Iron Metabolism and Related Disorders
Ginzburg, Y. Z., & Finberg, K. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-812535-9.00012-1 · Cited by 4
Lessons Learned from Genetic and Nutritional Iron Deficiencies
Chung, & Wessling-Resnick (2004) · Nutrition Reviews · doi:10.1111/j.1753-4887.2004.tb00042.x · Cited by 4
Milward, E. A., Trinder, D., Wilcox, C., Britton, R. S., Ramm, G. A., Olynyk, J. K., Jaeschke, H., Mullen, K. D., & Moradpour, D. (2005) · Hepatology · doi:10.1002/hep.20652 · Cited by 5
Surcharges en fer héréditaires non liées au gène HFE
Aguilar‐Martinez, P. (2007) · La Presse Médicale · doi:10.1016/j.lpm.2007.01.042 · Cited by 5
Gall, J. L., Jouanolle, A., Mosser, J., & David, V. (2005) · PubMed · Cited by 4
Actualités sur l’hémochromatose
Loréal, O., Lan, C. L., Troadec, M., Guyader, D., & Brissot, P. (2004) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(04)94993-7 · Cited by 4
Iron Deficiency, Iron Overload and Therapy
Crichton, R. R. (2016) · Wiley eBooks · doi:10.1002/9781118925645.ch11 · Cited by 4
HFE-Associated Hereditary Hemochromatosis
Skoien, R., & Powell, L. W. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_19 · Cited by 3
ДОНАЦІЇ КРОВІ І МЕТАБОЛІЗМ ЗАЛІЗА
Видиборець, С. В., & Дерпак, Ю. (2022) · Іnternational Science Group eBooks · doi:10.46299/979-8-88831-933-8 · Cited by 4
Molecular Regulation of Systemic Iron Metabolism
Ganz, T., & Vaulont, S. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_9 · Cited by 6
Prévenir et guérir les surcharges en fer, les espoirs de l’hepcidine
Viatte, L., & Vaulont, S. (2006) · Érudit (Université de Montréal) · doi:10.7202/013774ar · Cited by 3
The Role of Hepcidin in Iron Homeostasis
Ganz, T. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-462-9_3 · Cited by 3
“, 2004; Nemeth, Roetto, Garozzo, Ganz, & Camaschella, 2005) and in mouse models (Nicolas et al., 2001; Ahmad et al., 2002; Bridle et al., 2003; Nicolas et al., 2003; Muckenthaler et al., 2003; Kawabata et al., 2005; Niederkofler, Salie, & Arber, 2005; Huang, J. L. Pinkus, G. S. Pinkus, Fleming, & Andrews, 2005) reveal…”
BackgroundPrévenir et guérir les surcharges en fer, les espoirs de l’hepcidine
Viatte, L., & Vaulont, S. (2006) · médecine/sciences · doi:10.1051/medsci/20062289696 · Cited by 3
“En croisant les souris malades Hfe-/- avec des souris transgéniques exprimant de façon constitutive et précoce l’hepcidine, nous avons effectivement pu montrer que l’hepcidine, quand elle est présente dès la naissance, peut empêcher l’apparition de la surcharge en fer qui s’opère normalement chez les souris Hfe-/- [3].”
BackgroundPLASMA FERRITIN AND HEPCIDIN LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Al-adhami, I. A. A., Al-Shamahy, H. A., & Al-Meeril, A. M. (2019) · Universal Journal of Pharmaceutical Research · doi:10.22270/ujpr.v4i1.231 · Cited by 4
Andrews, N. C. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_87 · Cited by 2
Nanozyme-synbiotics to improve iron-deficiency anemia
Wu, A., Li, X., Kuang, Z., Gu, K., Luo, Y., Chen, D., & Wang, X. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114960 · Cited by 3
Paubelle, É., & Herbaux, C. (2013) · Hématologie · doi:10.1684/hma.2013.0805 · Cited by 3
Régulation de l'absorption du fer : données nouvelles
Cattan, D. (2004) · EMC - Hépatologie · doi:10.1016/j.emchep.2004.03.002 · Cited by 4
Hepcidin and the Hormonal Control of Iron Homeostasis
Frazer, D. M., & Anderson, G. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802168-2.00015-4 · Cited by 3
Dual diagnoses of hereditary hyperferritinaemia-cataract syndrome and hereditary haemochromatosis
Hughes, M., & Vosylius, P. (2006) · Clinical & Laboratory Haematology · doi:10.1111/j.1365-2257.2006.00824.x · Cited by 2
Ironing out haemochromatosis : a study of an Indian family
Hallendorff, M.-A. (2008) · SUNScholar (Stellenbosch University) · Cited by 4
Role of Hepcidin in Dysregulation of Iron Metabolism and Anemia of Chronic Diseases
Singh, B. M., Arora, S., Gupta, S., & Saxena, A. (2012) · BiblioBoard Library Catalog (Open Research Library) · doi:10.5772/27286 · Cited by 1
“Hemochromatosis protein (HFE) is an atypical major histocompability class I protein, located on chromosome 6 [79].”
BackgroundInfluentialThe iron sensor: macrophage, hepatocyte, both?
Fleming, R. E. (2005) · Blood · doi:10.1182/blood-2005-07-2673 · Cited by 1
Mécanismes impliqués dans la régulation de l’absorption intestinale du fer
Nicolas, G., Vaulont, S., & Beaumont, C. (2004) · Cahiers de Nutrition et de Diététique · doi:10.1016/s0007-9960(04)94453-7 · Cited by 3
Desbenoît, N., Galardon, E., Deschamps, P., Roussel, P., Vaulont, S., Artaud, I., & Tomás, A. (2010) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2010.08.002 · Cited by 1
Pocket-sized iron regulators: one size fits all?
Subramaniam, V. N. (2016) · Blood · doi:10.1182/blood-2016-05-716043 · Cited by 1
Mufadhal, E. A., Al-Showafi, F. K., Al-Shamahy, H. A., & Al-zabidi, E. M. (2019) · Universal Journal of Pharmaceutical Research · doi:10.22270/ujpr.v4i5.313 · Cited by 1
Iron in mammals: pathophysiological mechanisms of overload and deficiency in relation to disease
Johnson, M. B., Enns, C. A., & Zhang, A. (2005) · Topics in current genetics · doi:10.1007/4735_99 · Cited by 1
Le métabolisme du fer chez l’homme
Gall, J. L., Jouanolle, A., Mosser, J., & David, V. (2005) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)33421-1 · Cited by 5
Colli, M. L. (2007) · Lume (Universidade Federal do Rio Grande do Sul) · Cited by 1
Santos, P. C. J. L. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2011.tde-04022011-110402 · Cited by 2
L’hepcidine :un nouveau regard sur le métabolisme du fer
Viatte, L., & Vaulont, S. (2005) · Hépato-Gastro & Oncologie Digestive · Cited by 7
Treating iron overload with hepcidin
Camaschella, C. (2006) · Blood · doi:10.1182/blood-2006-01-0189 · Cited by 3
Chalès, G., Guggenbuhl, P., Jouanolle, A., & Loréal, O. (2010) · Revue du Rhumatisme Monographies · doi:10.1016/j.monrhu.2010.06.001 · Cited by 2
L'hepcidine, le chef d'orchestre de l'homéostasie du fer
Nicolas, G. (2009) · HAL · Cited by 1
Modulation of Gene Expression by Dietary Iron
Sharp, P. (2005) · Oxidative stress and disease · doi:10.1201/9781420028096.ch20 · Cited by 1
Iron-Regulatory Function of Hepcidin in the Channel Catfish and Western Clawed Frog
Hu, X. (2008) · Cited by 1
NEW INSIGHTS INTO THE HEPATIC IRON PHENOTYPE OF BMP6 KNOCKOUT MICEPreprint
Besson‐Fournier, C., Willemetz, A., Latour, C., Robert, L., Coppin, H., Roth, M., & Canonne‐Hergaux, F. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.28.559941 · Cited by 2
Anämien chronischer Erkrankungen
Muckenthaler, M. U., & Kulozik, A. E. (2005) · Springer eBooks · doi:10.1007/3-540-29036-2_16 · Cited by 1
Iron Homeostasis: Hepcidin Regulation
Camaschella, C., & Silvestri, L. (2004) · Wiley eBooks · doi:10.1002/9781119951438.eibc2131
Delaby, C., Oustric, V., Schmitt, C., Muzeau, F., Robréau, A.-M., Lettéron, P., Couchi, E., Yu, A., Lyoumi, S., Deybach, J., et al. (2013) · Mammalian Genome · doi:10.1007/s00335-013-9479-6 · Cited by 1
“Genetic hemochromatosis comprises a group of inherited disorders leading to primary iron overload resulting from an unregulated increase in the absorption of dietary iron due to inappropriate levels of hepcidin (Nicolas et al. 2003; Pietrangelo 2010).”
BackgroundKerlan, V. (2008) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(08)74924-1
« Tiktaalik, un pas décisif vers la terre ferme / Tiktaalik: a breakthrough towards firm land »
Tostivint, H., & Vaudry, H. (2015)
Regulation of hepcidin and hemojuvelin expression and their role in iron homeostasis
Salama, M. (2010) · UCL Discovery (University College London)
Mutations du gène HFE dans le cancer épithélial de l'ovaire
Medelci, S. (2008) · doi:10.71781/31650
Iron: Molecular Basis of Hemochromatosis
Schmidt, P. J. (2004) · Wiley eBooks · doi:10.1002/9781119951438.eibc2137
Beaumont, C. (2004)
Hereditary hemochromatosis : with a special emphasis on HFE genotyping
Hannuksela, J. (2004) · Cited by 2
Jereza, N. A. (2016) · UWE Research Repository (UWE Bristol)
Schmidt, P. J., Toudjarska, I., Sendamarai, A. K., Racie, T., Milstein, S., Bettencourt, B. R., Hettinger, J. L., Bumcrot, D. A., & Fleming, M. D. (2017)
BRAIN IRON DEFICIENCY IN HUMANS AND ANIMAL MODELS
Clardy, S. L. (2005)
IN TRANSLATION Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
Babitt, J. L., & Lin, H. Y.-F. (2010)
Hereditary haemochromatosis: the genes and the disease
Corradini, E., Ferrara, F., & Pietrangelo, A. (2007) · Springer eBooks · doi:10.1007/1-4020-5224-3_18
L’hepcidine: Fer de lance de la guérison des maladies chroniques inflammatoires de l’intestin
Renassia, C., & Peyssonnaux, C. (2021) · médecine/sciences · doi:10.1051/medsci/2021074 · Cited by 1
Las uniones de hecho en la nueva LEC
Señal, M. C. (2001) · Manuales de formación continuada
Vaulont, S. (2021) · médecine/sciences · doi:10.1051/medsci/2021228
Cunnane, G. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00118-3
Philpott, C. C. (2004) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1019260.232462
Pietrangelo, A. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch16b
(2009) · Wiley eBooks · doi:10.1002/9780470447758.refs
Griffiths, W. J., & Cox, T. M. (2020) · doi:10.1093/med/9780198746690.003.0233
Cunnane, G. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3285-4.10108-1
Metadata
- Authors
- Nicolas, G., Viatte, L., Lou, D.-Q., Bennoun, M., Beaumont, C., Kahn, A., Andrews, N. C., & Vaulont, S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Vaulont, Sophie
- Venue
- Nature Genetics
- Published
- 2003-04-21
- Volume
- 34
- Issue
- 1
- Pages
- 97-101
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2018391935
- Cited by
- 311
- References
- 25
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 2 · 2021: 6 · 2020: 6 · 2019: 11 · 2018: 7 · 2017: 9 · 2016: 10 · 2015: 7 · 2014: 8 · 2013: 11 · 2012: 8
- FWCI
- 19.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- hereditary hemochromatosis, hepcidin, HFE gene, Hfe knockout mice, iron overload, hyperferremia, hepatic iron deposition, intestinal iron absorption, reticuloendothelial cells, iron homeostasis
- MeSH terms
- Hemochromatosis Protein, Animals, Crosses, Genetic, Hemochromatosis, Humans, Membrane Proteins, Mice, Transgenic, Phenotype, RNA, Messenger, Histocompatibility Antigens Class I, Gene Expression, Mice, Knockout, Iron Overload, Mutation, Missense, Antimicrobial Cationic Peptides, Mice, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.